Search





Search





Tenaya Therapeutics Inc

TNYA

Add to Watchlist

0.718USD

-0.010-1.43%

Market hours （ET）Quotes delayed by 15 min

160.93MMarket Cap

LossP/E TTM

Tenaya Therapeutics Inc

0.718

-0.010-1.43%

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial Summary Income Statement Balance Sheet Cash Flow Statement Earnings Company Valuation Risk Assessment

TNYA Cash Flow Statement

You can access the annual and quarterly cash flow statements of Tenaya Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

77.25%-3.55M

16.78%-19.23M

24.19%-13.94M

21.36%-15.60M

33.89%-15.61M

19.36%-23.11M

16.13%-18.39M

16.08%-19.84M

9.93%-23.62M

5.38%-28.66M

3.34%-21.92M

14.22%-23.64M

-3.11%-26.22M

-5.33%-30.29M

-38.75%-22.68M

-65.43%-27.56M

-111.58%-25.43M

-82.13%-28.76M

-57.17%-16.35M

-74.71%-16.66M

-65.23%-12.02M

-91.66%-15.79M

---10.40M

---9.53M

---7.27M

---8.24M

Net income from continuing operations

-86.37%-43.39M

28.26%-19.27M

15.36%-20.18M

20.91%-20.27M

20.89%-23.28M

16.64%-26.86M

20.37%-23.84M

12.04%-25.63M

11.54%-29.43M

-1.55%-32.23M

10.68%-29.93M

5.06%-29.14M

-17.16%-33.27M

-2.19%-31.74M

-28.16%-33.52M

-68.09%-30.70M

-86.70%-28.40M

-137.10%-31.06M

-153.45%-26.15M

-77.39%-18.26M

-74.21%-15.21M

-44.71%-13.10M

---10.32M

---10.29M

---8.73M

---9.05M

Operating gains losses

1028.55%23.52M

-33.75%1.76M

-12.54%1.83M

-11.28%1.86M

-1.84%2.08M

23.48%2.66M

-4.22%2.09M

-3.67%2.10M

-3.28%2.12M

1.17%2.15M

3.02%2.18M

4.50%2.18M

69.24%2.19M

120.50%2.13M

167.64%2.12M

179.76%2.09M

76.46%1.30M

40.20%966.00K

20.21%791.00K

18.23%746.00K

20.49%735.00K

17.98%689.00K

--658.00K

--631.00K

--610.00K

--584.00K

Other non-cash items

-23.95%670.00K

4.31%654.00K

29.03%640.00K

-27.70%736.00K

-8.70%881.00K

-13.87%627.00K

-80.10%496.00K

111.64%1.02M

236.24%965.00K

289.30%728.00K

605.95%2.49M

-10.59%481.00K

-49.91%287.00K

-60.63%187.00K

-20.85%353.00K

70.79%538.00K

117.87%573.00K

177.78%475.00K

--446.00K

--315.00K

--263.00K

--171.00K

--0.00

Change in working capital

1172.19%12.81M

-33.42%-4.58M

186.20%893.00K

30.07%-921.00K

151.93%1.01M

5.61%-3.44M

-54.40%-1.04M

-7.60%-1.32M

-383.89%-1.94M

17.97%-3.64M

-113.45%-671.00K

53.95%-1.22M

135.15%683.00K

-259.19%-4.44M

-33.17%4.99M

-521.03%-2.66M

-214.90%-1.94M

68.99%-1.23M

891.30%7.46M

-615.66%-428.00K

179.50%1.69M

-19066.67%-3.98M

---943.00K

--83.00K

--605.00K

--21.00K

-Change in receivables

--10.26M

---10.63M

----

-Change in prepaid expenses

-23.05%1.50M

98.04%-9.00K

1.18%-167.00K

-591.07%-774.00K

181.91%1.95M

-202.91%-460.00K

91.16%-169.00K

-108.75%-112.00K

88.28%691.00K

22.13%447.00K

-655.81%-1.91M

145.07%1.28M

131.37%367.00K

-50.00%366.00K

15.05%344.00K

9.03%-2.84M

-4580.00%-1.17M

520.34%732.00K

148.54%299.00K

-8115.79%-3.12M

-113.59%-25.00K

-25.32%118.00K

---616.00K

---38.00K

--184.00K

--158.00K

-Change in other current assets

-107.34%-37.00K

11425.00%461.00K

-103.57%-2.00K

-73.90%65.00K

67.44%504.00K

-92.00%4.00K

-1.75%56.00K

266.18%249.00K

133.86%301.00K

-69.33%50.00K

139.86%57.00K

112.59%68.00K

-466.24%-889.00K

552.00%163.00K

-180.39%-143.00K

-395.41%-540.00K

-143.73%-157.00K

100.75%25.00K

-325.00%-51.00K

-938.46%-109.00K

3091.67%359.00K

-1860.36%-3.31M

---12.00K

--13.00K

---12.00K

---169.00K

-Change in other current liabilities

---739.00K

--10.40M

--102.00K

----

107.14%1.00K

-100.00%0.00

-116.28%-14.00K

-93.55%6.00K

131.25%5.00K

--2.00K

140.38%86.00K

144.50%93.00K

91.88%-16.00K

100.00%0.00

---213.00K

---209.00K

---197.00K

---190.00K

Cash from non-recurring investing activities

Cash from operating activities

77.25%-3.55M

16.78%-19.23M

24.19%-13.94M

21.36%-15.60M

33.89%-15.61M

19.36%-23.11M

16.13%-18.39M

16.08%-19.84M

9.93%-23.62M

5.38%-28.66M

3.34%-21.92M

14.22%-23.64M

-3.11%-26.22M

-5.33%-30.29M

-38.75%-22.68M

-65.43%-27.56M

-111.58%-25.43M

-82.13%-28.76M

-57.17%-16.35M

-74.71%-16.66M

-65.23%-12.02M

-91.66%-15.79M

---10.40M

---9.53M

---7.27M

---8.24M

Investing cash flow

Net cash from continuing investing activities

11.97%159.00K

-97.13%11.00K

-67.16%67.00K

-85.87%26.00K

94.52%142.00K

-32.09%383.00K

-48.22%204.00K

2200.00%184.00K

-64.90%73.00K

-10.33%564.00K

-50.44%394.00K

-99.80%8.00K

-97.10%208.00K

-92.68%629.00K

-93.67%795.00K

-18.85%4.06M

121.76%7.18M

98.82%8.60M

53.53%12.55M

2991.36%5.01M

227.20%3.24M

893.79%4.32M

--8.18M

--162.00K

--989.00K

--435.00K

Capital expenditures

11.97%159.00K

-97.13%11.00K

-67.16%67.00K

-85.87%26.00K

94.52%142.00K

-32.09%383.00K

-48.22%204.00K

2200.00%184.00K

-64.90%73.00K

-10.33%564.00K

-50.44%394.00K

-99.80%8.00K

-97.10%208.00K

-92.68%629.00K

-93.67%795.00K

-18.85%4.06M

121.76%7.18M

98.82%8.60M

53.53%12.55M

2991.36%5.01M

227.20%3.24M

893.79%4.32M

--8.18M

--162.00K

--989.00K

--435.00K

Net cash flow from disposal of fixed assets

11.97%159.00K

-97.13%11.00K

-67.16%67.00K

-85.87%26.00K

94.52%142.00K

-32.09%383.00K

-48.22%204.00K

2200.00%184.00K

-64.90%73.00K

-10.33%564.00K

-50.44%394.00K

-99.80%8.00K

-97.10%208.00K

-92.68%629.00K

-93.67%795.00K

-18.85%4.06M

121.76%7.18M

98.82%8.60M

53.53%12.55M

2991.36%5.01M

227.20%3.24M

893.79%4.32M

--8.18M

--162.00K

--989.00K

--435.00K

Net cash flow from investment products

-100.00%0.00

129.69%8.89M

15.89%25.13M

677.81%22.68M

198.62%14.31M

-198.12%-29.93M

-14.24%21.68M

-145.12%-3.93M

-314.57%-14.51M

-13.10%30.50M

-32.37%25.28M

-65.23%8.70M

113.51%6.76M

121.48%35.10M

--37.39M

--25.03M

---50.03M

---163.42M

--0.00

-100.00%0.00

--0.00

--2.75M

Net cash flow from other investing activities

--0.00

-100.00%0.00

----

100.00%0.00

400.00%12.00K

-55.56%4.00K

108.33%1.00K

-325.00%-18.00K

---4.00K

--9.00K

---12.00K

--8.00K

----

Cash from non-current investing activities

Net cash flow from investing activities

-100.64%-159.00K

-100.05%-11.00K

-100.48%-67.00K

129.44%8.86M

15.60%24.99M

596.81%22.30M

194.53%14.10M

-198.72%-30.10M

-13.83%21.61M

-155.69%-4.49M

-349.73%-14.92M

-1.76%30.49M

-16.96%25.09M

-50.95%8.06M

109.55%5.97M

118.43%31.03M

1033.56%30.21M

480.15%16.43M

-665.32%-62.58M

-103866.05%-168.43M

-227.20%-3.24M

-286.50%-4.32M

---8.18M

---162.00K

---989.00K

--2.32M

Financing cash flow

Cash flow from continuous financing activities

290.97%909.00K

-100.83%-415.00K

15348.81%58.24M

1125.81%380.00K

-183.51%-476.00K

7.46%50.26M

1.62%377.00K

--31.00K

-86.36%570.00K

9435.53%46.77M

-99.52%371.00K

-100.00%0.00

1507.31%4.18M

-3440.00%-501.00K

369080.95%77.49M

-100.00%6.00K

120.03%260.00K

-99.93%15.00K

-100.02%-21.00K

519.89%190.27M

-6080.95%-1.30M

-34.74%20.02M

--85.92M

--30.70M

---21.00K

--30.67M

Net cash flow from common stock issuance/repurchase

----

--56.26M

--0.00

---544.00K

5.52%49.34M

--0.00

--46.76M

-100.00%0.00

----

121017.19%77.39M

-100.00%0.00

----

---64.00K

18860300.00%188.60M

---10.00K

----

--0.00

---1.00K

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--0.00

-34.83%19.99M

--85.95M

--30.68M

--0.00

--30.67M

Proceeds from stock option exercised by employees

-38.57%43.00K

----

-87.84%45.00K

-22.58%24.00K

-87.72%70.00K

----

-0.27%370.00K

--31.00K

83.28%570.00K

--8.00K

274.75%371.00K

-100.00%0.00

19.62%311.00K

-100.00%0.00

219.35%99.00K

-97.88%6.00K

738.71%260.00K

-48.28%15.00K

82.35%31.00K

2258.33%283.00K

1450.00%31.00K

866.67%29.00K

--17.00K

--12.00K

--2.00K

--3.00K

Proceeds from issuance of warrants

--866.00K

----

27514.29%1.93M

--356.00K

----

--7.00K

--0.00

--1.00K

----

Net cash flow from other financing activities

100.00%0.00

-145.40%-415.00K

--0.00

---2.00K

--914.00K

----

--0.00

-100.00%0.00

100.00%0.00

--0.00

--3.87M

---501.00K

-100.00%0.00

----

127.27%12.00K

--1.39M

-5634.78%-1.32M

----

---44.00K

----

---23.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

290.97%909.00K

-100.83%-415.00K

15348.81%58.24M

1125.81%380.00K

-183.51%-476.00K

7.46%50.26M

1.62%377.00K

--31.00K

-86.36%570.00K

9435.53%46.77M

-99.52%371.00K

-100.00%0.00

1507.31%4.18M

-3440.00%-501.00K

369080.95%77.49M

-100.00%6.00K

120.03%260.00K

-99.93%15.00K

-100.02%-21.00K

519.89%190.27M

-6080.95%-1.30M

-34.74%20.02M

--85.92M

--30.70M

---21.00K

--30.67M

Net cash flow

Beginning cash balance

50.04%81.31M

2029.19%100.97M

555.85%56.73M

7.75%63.09M

-9.66%54.19M

-89.77%4.74M

-89.56%8.65M

-22.94%58.55M

-17.76%59.98M

-51.54%46.36M

137.40%82.83M

141.92%75.98M

176.62%72.94M

147.37%95.67M

-70.34%34.89M

-72.06%31.41M

-79.56%26.37M

-70.04%38.68M

90.53%117.62M

175.99%112.43M

163.12%128.99M

431.84%129.08M

--61.74M

--40.74M

--49.02M

--24.27M

Current period cash flow changes

-131.49%-2.80M

-139.76%-19.66M

1231.91%44.23M

87.26%-6.36M

721.44%8.90M

263.01%49.45M

89.28%-3.91M

-828.51%-49.90M

-147.04%-1.43M

159.93%13.62M

-160.01%-36.47M

96.61%6.85M

-39.60%3.04M

-84.69%-22.73M

176.98%60.78M

-32.90%3.48M

130.45%5.04M

-12587.63%-12.31M

-217.23%-78.95M

-75.28%5.19M

-99.82%-16.55M

-100.39%-97.00K

--67.35M

--21.00M

---8.28M

--24.75M

Ending cash balance

24.43%78.50M

50.04%81.31M

2029.19%100.97M

555.85%56.73M

7.75%63.09M

-9.66%54.19M

-89.77%4.74M

-89.56%8.65M

-22.94%58.55M

-17.76%59.98M

-51.54%46.36M

137.40%82.83M

141.92%75.98M

176.62%72.94M

147.37%95.67M

-70.34%34.89M

-72.06%31.41M

-79.56%26.37M

-70.04%38.68M

90.53%117.62M

176.00%112.43M

163.12%128.99M

--129.08M

--61.74M

--40.74M

--49.02M

Free cash flow

76.45%-3.71M

18.09%-19.25M

24.66%-14.01M

21.95%-15.63M

33.50%-15.76M

19.60%-23.50M

16.70%-18.59M

15.33%-20.02M

10.36%-23.69M

5.48%-29.22M

4.94%-22.32M

25.22%-23.65M

18.95%-26.43M

17.22%-30.92M

18.77%-23.48M

-45.95%-31.62M

-113.74%-32.61M

-85.71%-37.35M

-55.57%-28.90M

-123.44%-21.66M

-84.62%-15.26M

-131.89%-20.11M

---18.58M

---9.70M

---8.26M

---8.67M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Tenaya Therapeutics Inc Generate?



Tenaya Therapeutics Inc generated -68.26M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Tenaya Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Tenaya Therapeutics Inc's operating cash flow increased by 24.57% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Tenaya Therapeutics Inc Spend on Capital Expenditures?



Tenaya Therapeutics Inc spent 618.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Tenaya Therapeutics Inc's Financing Cash Flow Changed?



Tenaya Therapeutics Inc used 108.41M in financing activities in the latest quarter.

What is free cash flow and why does it matter for TNYA?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Tenaya Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -68.88M reflecting a 24.74% change from the previous year.